The headline study claiming anti-trans laws caused a 72 percent spike in teen suicide attempts has been challenged by peer review and reanalysis, exposing serious methodological problems and casting doubt on conclusions that had already shaped media coverage and policy debates.
A prominent paper in Nature Human Behavior credited the Trevor Project with findings that “anti-transgender laws increased incidents of past-year suicide attempts” among teens by as much as 72 percent. That statistic spread fast, picked up by major outlets and cited by medical groups and policy advocates as if it were settled science. What has followed is a thorough academic reexamination that raises hard questions about how the original numbers were produced and used.
The study’s co-author, Ronita Nath, told CNN, “We’ve long known that the associations between anti-transgender policies and negative health outcomes for LGBTQ+ young people exist, but this is the first time any study has shown this causal relationship.” That quote remains on record and was used to push the study into the headlines. But the peer-reviewed critique by Cohn et al. shows that the bold causal language was not matched by robust data or sound internal checks.
https://x.com/LeorSapir/status/2066946138448494612
Cohn and others pointed out that the striking 72 percent figure came from a single state with a tiny sample, roughly 60–100 youth, and that the data window used predates any relevant law being in place. When a purported effect appears before a law exists, causality is impossible and the result must be treated as suspect. The reanalysis also found that the authors’ model produced similar “effects” when run against outcomes the law could not plausibly affect, like employment and homelessness, which suggests confounding factors were at work.
The Trevor Project issued a response defending Idaho’s inclusion and insisting that “The concerns raised by Cohn et al. do not alter the interpretation of our findings.” That statement stands as their public position, but critics say it sidesteps the timing problem and the small-sample issue that undercut the core headline number. Independent groups, including the Society for Evidence-Based Gender Medicine, have cataloged why the responses did not resolve the technical flaws identified in the critique.
This episode fits into a wider pattern in which high-profile studies with dramatic claims get amplified before scrutiny catches up. The U.K.’s 2022 Cass Review challenged several foundational assumptions by finding no reliable evidence that gender-affirming procedures reduce suicide rates or consistently improve mental health. That review flagged earlier studies for lacking standard clinical safeguards such as adequate control groups, robust sample sizes, and transparent reporting.
Despite those flaws, organizations like the American Psychiatric Association and the American Medical Association have at times leaned on such studies when shaping guidelines and education. When the research feeding policy is weak, the policies based on it risk being built on shaky ground. Conservatives arguing for rigorous, unbiased science see this as a warning sign that ideology, not evidence, too often drives the narrative.
The consequences are real: legislation, clinical practice, and public opinion can shift based on studies that later don’t hold up. Policymakers and doctors rely on the literature to make life-impacting decisions for young people, and errors in high-profile research can distort those choices. That’s why methodological clarity and independent replication aren’t optional; they are essential to responsible policymaking and medical care.
Accusations of bias have followed the Trevor Project paper, including critiques about language and framing that treated certain policies as inherently “anti-trans” without parsing different policy intentions or social contexts. Critics argue that labeling laws and policies in ideological terms can color both analysis and interpretation, and that serious research must avoid advocacy framing that pre-commits the conclusion.
For Republicans and others skeptical of research shaped by advocacy groups, this case underscores two priorities: demand rigorous methods, and resist letting loud headlines replace careful science. Medical journals and professional bodies must uphold higher standards for causal claims, especially when studies are used to influence legislation or clinical practice. If the data are weak, the debate should reflect that uncertainty rather than pretending the evidence is settled.
Ultimately the reexamination does not deny that young people face real mental health challenges; it questions whether a single flawed study should have been allowed to so quickly steer public debate and professional guidance. Accurate, clinically sound research must be the baseline — not headline-driven activism dressed up as science — if we want policy that actually helps vulnerable teens instead of misdirecting resources and trust.
